Full Text View
Tabular View
No Study Results Posted
Related Studies
Glucose Optimisation With Angiotensin II Antagonist Losartan (GOAAL)
This study has been completed.
Study NCT00237588   Information provided by Ullevaal University Hospital
First Received: October 10, 2005   Last Updated: November 2, 2006   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hypertension
More general conditions related to this trial
Cardiovascular Diseases
Vascular Diseases
Additional drug interventions recognized in this trial
Amlodipine
Angiotensin II
Calcium Channel Blockers
Losartan
More general drug interventions related to this trial
Angiotensin II Type 1 Receptor Blockers
Anti-Arrhythmia Agents
Antihypertensive Agents
Cardiovascular Agents
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Vasoconstrictor Agents
Vasodilator Agents
Sponsors listed in this trial
Ullevaal University Hospital
Merck


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services